Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial

BACKGROUND: The World Health Organization recommends quinine plus clindamycin as first-line treatment of malaria in the first trimester of pregnancy and as a second-line treatment for uncomplicated falciparum malaria when artemisinin-based drug combinations are not available. The efficacy of quinine...

Descripción completa

Detalles Bibliográficos
Autores principales: Obonyo, Charles O., Juma, Elizabeth A., Were, Vincent O., Ogutu, Bernhards R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809037/
https://www.ncbi.nlm.nih.gov/pubmed/35109841
http://dx.doi.org/10.1186/s12936-022-04050-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809037/
https://www.ncbi.nlm.nih.gov/pubmed/35109841
http://dx.doi.org/10.1186/s12936-022-04050-8

Ejemplares similares